Canada markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
896.82+2.83 (+0.32%)
At close: 04:00PM EDT
840.11 -56.71 (-6.32%)
After hours: 04:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 98.44B
Enterprise Value 90.30B
Trailing P/E 25.79
Forward P/E 19.96
PEG Ratio (5 yr expected) 1.45
Price/Sales (ttm)7.77
Price/Book (mrq)3.79
Enterprise Value/Revenue 6.88
Enterprise Value/EBITDA 19.24

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 312.52%
S&P500 52-Week Change 320.07%
52 Week High 3998.33
52 Week Low 3684.81
50-Day Moving Average 3952.79
200-Day Moving Average 3859.22

Share Statistics

Avg Vol (3 month) 3470.19k
Avg Vol (10 day) 3500.74k
Shares Outstanding 5107.94M
Implied Shares Outstanding 6109.76M
Float 8102.75M
% Held by Insiders 12.58%
% Held by Institutions 189.29%
Shares Short (Mar 28, 2024) 41.42M
Short Ratio (Mar 28, 2024) 43.19
Short % of Float (Mar 28, 2024) 41.54%
Short % of Shares Outstanding (Mar 28, 2024) 41.30%
Shares Short (prior month Feb 29, 2024) 41.36M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 30.14%
Operating Margin (ttm)29.20%

Management Effectiveness

Return on Assets (ttm)8.49%
Return on Equity (ttm)16.26%

Income Statement

Revenue (ttm)13.12B
Revenue Per Share (ttm)122.93
Quarterly Revenue Growth (yoy)0.60%
Gross Profit (ttm)N/A
EBITDA 4.65B
Net Income Avi to Common (ttm)3.95B
Diluted EPS (ttm)34.76
Quarterly Earnings Growth (yoy)-3.10%

Balance Sheet

Total Cash (mrq)10.84B
Total Cash Per Share (mrq)100.92
Total Debt (mrq)2.79B
Total Debt/Equity (mrq)10.74%
Current Ratio (mrq)5.69
Book Value Per Share (mrq)242.47

Cash Flow Statement

Operating Cash Flow (ttm)4.59B
Levered Free Cash Flow (ttm)2.76B